-
1
-
-
77954814751
-
Evolving molecules using multi-objective optimization: Applying to ADME/Tox
-
Jun
-
Ekins S, Honeycutt JD, Metz JT. Evolving molecules using multi-objective optimization: applying to ADME/Tox. Drug Discov Today 2010 Jun; 15 (11-12): 451-60.
-
(2010)
Drug Discov Today
, vol.15
, Issue.11-12
, pp. 451-460
-
-
Ekins, S.1
Honeycutt, J.D.2
Metz, J.T.3
-
2
-
-
79956348442
-
Alternative (non-animal) methods for cosmetics testing: Current status and future prospects - 2010
-
May
-
Adler S, Basketter D, Creton S, et al. Alternative (non-animal) methods for cosmetics testing: current status and future prospects - 2010. Arch Toxicol 2011 May; 85 (5): 367-485.
-
(2011)
Arch Toxicol
, vol.85
, Issue.5
, pp. 367-485
-
-
Adler, S.1
Basketter, D.2
Creton, S.3
-
3
-
-
22244480365
-
Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapy
-
DOI 10.2165/00003088-200544060-00003
-
Barrett JS, Labbe L, Pfister M. Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapy. Clin Pharmacokinet 2005; 44 (6): 591-625. (Pubitemid 40994087)
-
(2005)
Clinical Pharmacokinetics
, vol.44
, Issue.6
, pp. 591-625
-
-
Barrett, J.S.1
Labbe, L.2
Pfister, M.3
-
4
-
-
33751116844
-
Innovative methods to study human intestinal drug metabolism in vitro: Precision-cut slices compared with Ussing chamber preparations
-
DOI 10.1124/dmd.106.011148
-
van de Kerkhof EG, Ungell AL, Sjoberg AK, et al. Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with Ussing chamber preparations. Drug Metab Dispos 2006 Nov; 34 (11): 1893-902. (Pubitemid 44771719)
-
(2006)
Drug Metabolism and Disposition
, vol.34
, Issue.11
, pp. 1893-1902
-
-
Van De Kerkhof, E.G.1
Ungell, A.-L.B.2
Sjoberg, A.K.3
De Jager, M.H.4
Hilgendorf, C.5
De Graaf, I.A.M.6
Groothuis, G.M.M.7
-
5
-
-
77149142588
-
Modelling of drug disposition ki- netics in in vitro intestinal absorption cell models
-
Mar
-
Heikkinen AT, Korjamo T, Monkkonen J. Modelling of drug disposition ki- netics in in vitro intestinal absorption cell models. Basic Clin Pharmacol Toxicol 2010 Mar; 106 (3): 180-8.
-
(2010)
Basic Clin Pharmacol Toxicol
, vol.106
, Issue.3
, pp. 180-188
-
-
Heikkinen, A.T.1
Korjamo, T.2
Monkkonen, J.3
-
6
-
-
55749099657
-
Validation of a rapid equilibrium dial- ysis approach for the measurement of plasma protein binding
-
Oct
-
Waters NJ, Jones R, Williams G, et al. Validation of a rapid equilibrium dial- ysis approach for the measurement of plasma protein binding. J Pharm Sci 2008 Oct; 97 (10): 4586-95.
-
(2008)
J Pharm Sci
, vol.97
, Issue.10
, pp. 4586-4595
-
-
Waters, N.J.1
Jones, R.2
Williams, G.3
-
7
-
-
40249118217
-
An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening
-
Apr
-
Culot M, Lundquist S, Vanuxeem D, et al. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. Toxicol In Vitro 2008 Apr; 22 (3): 799-811.
-
(2008)
Toxicol in Vitro
, vol.22
, Issue.3
, pp. 799-811
-
-
Culot, M.1
Lundquist, S.2
Vanuxeem, D.3
-
8
-
-
34247556082
-
Mechanistic approaches to volume of distribution predictions: Understanding the processes
-
DOI 10.1007/s11095-006-9210-3
-
Rodgers T, Rowland M. Mechanistic approaches to volume of distribution predictions: understanding the processes. Pharm Res 2007 May;24(5): 918-33. (Pubitemid 46675393)
-
(2007)
Pharmaceutical Research
, vol.24
, Issue.5
, pp. 918-933
-
-
Rodgers, T.1
Rowland, M.2
-
9
-
-
15244345304
-
Prediction of drug metabolism and interactions on the basis of in vitro investigations
-
DOI 10.1111/j.1742-7843.2005.pto960305.x
-
Pelkonen O, Turpeinen M, Uusitalo J, et al. Prediction of drug metabolism and interactions on the basis of in vitro investigations. Basic Clin Pharmacol Toxicol 2005 Mar; 96 (3): 167-75. (Pubitemid 40387992)
-
(2005)
Basic and Clinical Pharmacology and Toxicology
, vol.96
, Issue.3
, pp. 167-175
-
-
Pelkonen, O.1
Turpeinen, M.2
Uusitalo, J.3
Rautio, A.4
Raunio, H.5
-
10
-
-
2942537923
-
Cellular models for ADMET predictions and evaluation of drug-drug interactions
-
Riley RJ, Kenna JG. Cellular models for ADMET predictions and evaluation of drug-drug interactions. Curr Opin Drug Discov Devel 2004 Jan; 7 (1): 86-99. (Pubitemid 44111917)
-
(2004)
Current Opinion in Drug Discovery and Development
, vol.7
, Issue.1
, pp. 86-99
-
-
Riley, R.J.1
Kenna, J.G.2
-
11
-
-
49649099527
-
An update on metabolism studies using human hepatocytes in primary culture
-
Jul
-
Gomez-Lechon MJ, Castell JV, Donato MT. An update on metabolism studies using human hepatocytes in primary culture. Expert Opin Drug Metab Toxicol 2008 Jul; 4 (7): 837-54.
-
(2008)
Expert Opin Drug Metab Toxicol
, vol.4
, Issue.7
, pp. 837-854
-
-
Gomez-Lechon, M.J.1
Castell, J.V.2
Donato, M.T.3
-
12
-
-
60749133620
-
Methods for predicting in vivo pharmacokinetics using data from in vitro assays
-
Nov
-
Houston JB, Galetin A. Methods for predicting in vivo pharmacokinetics using data from in vitro assays. Curr Drug Metab 2008 Nov; 9 (9): 940-51.
-
(2008)
Curr Drug Metab
, vol.9
, Issue.9
, pp. 940-951
-
-
Houston, J.B.1
Galetin, A.2
-
13
-
-
55049100842
-
Inhibition and induction of human cytochrome P450 enzymes: Current status
-
Oct
-
Pelkonen O, Turpeinen M, Hakkola J,et al. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 2008 Oct; 82 (10): 667-715.
-
(2008)
Arch Toxicol
, vol.82
, Issue.10
, pp. 667-715
-
-
Pelkonen, O.1
Turpeinen, M.2
Hakkola, J.3
-
14
-
-
34247492532
-
The pivotal role of hepatocytes in drug discovery
-
DOI 10.1016/j.cbi.2006.11.002, PII S0009279706003255
-
Soars MG, McGinnity DF, Grime K, et al. The pivotal role of hepatocytes in drug discovery. Chem Biol Interact 2007 May 20; 168 (1): 2-15. (Pubitemid 46661937)
-
(2007)
Chemico-Biological Interactions
, vol.168
, Issue.1
, pp. 2-15
-
-
Soars, M.G.1
McGinnity, D.F.2
Grime, K.3
Riley, R.J.4
-
15
-
-
71949098636
-
Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: Use of assays and models for decision making in the pharmaceutical industry
-
Nov-Dec
-
Soars MG, Webborn PJ, Riley RJ. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry. Mol Pharm 2009 Nov-Dec; 6 (6): 1662-7.
-
(2009)
Mol Pharm
, vol.6
, Issue.6
, pp. 1662-7
-
-
Soars, M.G.1
Webborn, P.J.2
Riley, R.J.3
-
16
-
-
38149129455
-
Xenobiotic transporters: Ascribing function from gene knockout and mutation studies
-
Feb
-
Klaassen CD, Lu H. Xenobiotic transporters: ascribing function from gene knockout and mutation studies. Toxicol Sci 2008 Feb; 101 (2): 186-96.
-
(2008)
Toxicol Sci
, vol.101
, Issue.2
, pp. 186-196
-
-
Klaassen, C.D.1
Lu, H.2
-
17
-
-
77949398878
-
Xenobiotic bile acid and cholesterol trans- porters: Function and regulation
-
Mar
-
Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol trans- porters: function and regulation. Pharmacol Rev 2010 Mar; 62 (1): 1-96.
-
(2010)
Pharmacol Rev
, vol.62
, Issue.1
, pp. 1-96
-
-
Klaassen, C.D.1
Aleksunes, L.M.2
-
18
-
-
35648944767
-
In vitro-in vivo extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations
-
DOI 10.1080/00498250701620726, PII 783596089, Modelling and Simulation Approaches to in vitro-in vivo, Extrapolation of ADME Properties in Drug Development, Editor: Gordon Gibson, Guest Editor: Amin Rostami-Hodjegan
-
Pelkonen O, Turpeinen M. In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations. Xenobiotica 2007 Oct-Nov; 37 (10-11): 1066-89. (Pubitemid 350035539)
-
(2007)
Xenobiotica
, vol.37
, Issue.10-11
, pp. 1066-1089
-
-
Pelkonen, O.1
Turpeinen, M.2
-
19
-
-
33645961595
-
The impact of in vitro binding on in vitro-in vivo extra- polations, projections of metabolic clearance and clinical drug-drug interactions
-
Apr
-
Grime K, Riley RJ. The impact of in vitro binding on in vitro-in vivo extra- polations, projections of metabolic clearance and clinical drug-drug interactions. Curr Drug Metab 2006 Apr; 7 (3): 251-64.
-
(2006)
Curr Drug Metab
, vol.7
, Issue.3
, pp. 251-264
-
-
Grime, K.1
Riley, R.J.2
-
20
-
-
65549132771
-
Methodologicaluncertainty in quantitative prediction of human hepatic clearance from in vitro experimental systems
-
Mar
-
Hallifax D, Houston JB. Methodologicaluncertainty in quantitative prediction of human hepatic clearance from in vitro experimental systems. Curr Drug Metab 2009 Mar; 10 (3): 307-21.
-
(2009)
Curr Drug Metab
, vol.10
, Issue.3
, pp. 307-321
-
-
Hallifax, D.1
Houston, J.B.2
-
21
-
-
35648929358
-
In vitro-in vivo extrapolation of hepatic clearance involving active uptake: Theoretical and experimental aspects
-
DOI 10.1080/00498250701557266, PII 783595910, Modelling and Simulation Approaches to in vitro-in vivo, Extrapolation of ADME Properties in Drug Development, Editor: Gordon Gibson, Guest Editor: Amin Rostami-Hodjegan
-
Webborn PJ, Parker AJ, Denton RL, et al. In vitro-in vivo extrapolation of hepatic clearance involving active uptake: theoretical and experimental aspects. Xenobiotica 2007 Oct-Nov; 37 (10-11): 1090-109. (Pubitemid 350035538)
-
(2007)
Xenobiotica
, vol.37
, Issue.10-11
, pp. 1090-1109
-
-
Webborn, P.J.H.1
Parker, A.J.2
Denton, R.L.3
Riley, R.J.4
-
22
-
-
34548304745
-
In silico pharmacology for drug discovery: Methods for virtual ligand screening and profiling
-
DOI 10.1038/sj.bjp.0707305, PII 0707305
-
Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol 2007 Sep; 152 (1): 9-20. (Pubitemid 47339896)
-
(2007)
British Journal of Pharmacology
, vol.152
, Issue.1
, pp. 9-20
-
-
Ekins, S.1
Mestres, J.2
Testa, B.3
-
23
-
-
34548319111
-
In silico pharmacology for drug discovery: Applications to targets and beyond
-
DOI 10.1038/sj.bjp.0707306, PII 0707306
-
Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: applications to targets and beyond. Br J Pharmacol 2007 Sep; 152 (1): 21-37. (Pubitemid 47339897)
-
(2007)
British Journal of Pharmacology
, vol.152
, Issue.1
, pp. 21-37
-
-
Ekins, S.1
Mestres, J.2
Testa, B.3
-
24
-
-
0036891062
-
In silico prediction of ADME and pharmacokinetics: Report of an expert meeting organised by COST B15
-
DOI 10.1016/S0928-0987(02)00185-9, PII S0928098702001859
-
Boobis A, Gundert-Remy U, Kremers P, et al. In silico prediction of ADME and pharmacokinetics: report of an expert meeting organised by COST B15. Eur J Pharm Sci 2002 Dec; 17 (4-5): 183-93. (Pubitemid 35365921)
-
(2002)
European Journal of Pharmaceutical Sciences
, vol.17
, Issue.4-5
, pp. 183-193
-
-
Boobis, A.1
Gundert-Remy, U.2
Kremers, P.3
Macheras, P.4
Pelkonen, O.5
-
25
-
-
0037364162
-
ADMET in silico modelling: Towards prediction paradise?
-
DOI 10.1038/nrd1032
-
van de Waterbeemd H, Gifford E. ADMET in silico modelling: towards pre- diction paradise? Nat Rev Drug Discov 2003 Mar; 2 (3): 192-204. (Pubitemid 37361664)
-
(2003)
Nature Reviews Drug Discovery
, vol.2
, Issue.3
, pp. 192-204
-
-
Van De Waterbeemd, H.1
Gifford, E.2
-
26
-
-
52649175489
-
Human cytochromes P450 in the metabolism of drugs: New molecular models of enzyme-substrate interactions
-
Sep
-
Lewis DF, Ito Y. Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme-substrate interactions. Expert Opin Drug Metab Toxicol 2008 Sep; 4 (9): 1181-6.
-
(2008)
Expert Opin Drug Metab Toxicol
, vol.4
, Issue.9
, pp. 1181-6
-
-
Lewis, D.F.1
Ito, Y.2
-
27
-
-
78650757034
-
From known knowns to known unknowns: Predicting in vivo drug metabolites
-
May
-
Pelkonen O, Tolonen A, Korjamo T, et al. From known knowns to known unknowns: predicting in vivo drug metabolites. Bioanalysis 2009 May; 1 (2): 393-414.
-
(2009)
Bioanalysis
, vol.1
, Issue.2
, pp. 393-414
-
-
Pelkonen, O.1
Tolonen, A.2
Korjamo, T.3
-
29
-
-
33749036300
-
Prediction of ADMET properties
-
DOI 10.1002/cmdc.200600155
-
Norinder U, Bergstrom CA. Prediction of ADMET properties. ChemMed- Chem 2006 Sep; 1 (9): 920-37. (Pubitemid 44448790)
-
(2006)
ChemMedChem
, vol.1
, Issue.9
, pp. 920-937
-
-
Norinder, U.1
Bergstrom, C.A.S.2
-
30
-
-
69249141066
-
Comprehensive assessment of ADMET risks in drug discovery
-
Wang J. Comprehensive assessment of ADMET risks in drug discovery. Curr Pharm Des 2009; 15 (19): 2195-219.
-
(2009)
Curr Pharm des
, vol.15
, Issue.19
, pp. 2195-219
-
-
Wang, J.1
-
31
-
-
66849113847
-
Recent developments of in silico predictions of intestinal absorption and oral bioavailability
-
Jun
-
Hou T, Li Y, Zhang W, et al. Recent developments of in silico predictions of intestinal absorption and oral bioavailability. Comb Chem High Throughput Screen 2009 Jun; 12 (5): 497-506.
-
(2009)
Comb Chem High Throughput Screen
, vol.12
, Issue.5
, pp. 497-506
-
-
Hou, T.1
Li, Y.2
Zhang, W.3
-
32
-
-
73849114964
-
Challenges in the prediction and modeling of oral absorption and bioavailability
-
Jan
-
Metcalfe PD, Thomas S. Challenges in the prediction and modeling of oral absorption and bioavailability. Curr Opin Drug Discov Devel 2010 Jan; 13 (1): 104-10.
-
(2010)
Curr Opin Drug Discov Devel
, vol.13
, Issue.1
, pp. 104-110
-
-
Metcalfe, P.D.1
Thomas, S.2
-
33
-
-
67649392513
-
A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry biology anatomy physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates
-
Jamei M, Dickinson GL, Rostami-Hodjegan A. A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: a tale of 'bottom-up' vs 'top-down' recognition of covariates. Drug Metab Pharmacokinet 2009; 24 (1): 53-75.
-
(2009)
Drug Metab Pharmacokinet
, vol.24
, Issue.1
, pp. 53-75
-
-
Jamei, M.1
Dickinson, G.L.2
Rostami-Hodjegan, A.3
-
34
-
-
33847035148
-
State-of-the-art tools for computational site of metabolism predictions: Comparative analysis, mechanistical insights, and future applications
-
Afzelius L, Arnby CH, Broo A, et al. State-of-the-art tools for computational site of metabolism predictions: comparative analysis, mechanistical insights, and future applications. Drug Metab Rev 2007; 39 (1): 61-86.
-
(2007)
Drug Metab Rev
, vol.39
, Issue.1
, pp. 61-86
-
-
Afzelius, L.1
Arnby, C.H.2
Broo, A.3
-
35
-
-
77953929952
-
The challenges of in silico contributions to drug metabolism in lead optimization
-
Jul
-
Vaz RJ, Zamora I, Li Y, et al. The challenges of in silico contributions to drug metabolism in lead optimization. Expert Opin Drug Metab Toxicol 2010 Jul; 6 (7): 851-61.
-
(2010)
Expert Opin Drug Metab Toxicol
, vol.6
, Issue.7
, pp. 851-861
-
-
Vaz, R.J.1
Zamora, I.2
Li, Y.3
-
36
-
-
47749149564
-
Predicting the volume of distribution of drugs in humans
-
DOI 10.2174/138920008784892137
-
Sui X, Sun J, Wu X, et al. Predicting the volume of distribution of drugs in humans. Curr Drug Metab 2008 Jul; 9 (6): 574-80. (Pubitemid 352025189)
-
(2008)
Current Drug Metabolism
, vol.9
, Issue.6
, pp. 574-580
-
-
Sui, X.1
Sun, J.2
Wu, X.3
Li, H.4
Liu, J.5
He, Z.6
-
37
-
-
60749087739
-
Assays to predict drug permeation across the blood-brain barrier, and distribution to brain
-
Nov
-
Abbott NJ, Dolman DE, Patabendige AK. Assays to predict drug permeation across the blood-brain barrier, and distribution to brain. Curr Drug Metab 2008 Nov; 9 (9): 901-10.
-
(2008)
Curr Drug Metab
, vol.9
, Issue.9
, pp. 901-910
-
-
Abbott, N.J.1
Dolman, D.E.2
Patabendige, A.K.3
-
38
-
-
35148898451
-
-
Organisation for Economic Cooperation and Development [OECD] OECD Series on Testing and Assessment, No. 69 [online] [Accessed 2011 Apr 20]
-
Organisation for Economic Cooperation and Development [OECD]. Guidance document on the validation of (quantitative) structure-activity relationships [(Q)SAR] models. OECD Series on Testing and Assessment, No. 69 [online]. Available from URL: http://www.oecd.org/document/2/0,3746,en-2649-34365- 42926338-1-1-1-1,00.html [Accessed 2011 Apr 20].
-
Guidance Document on the Validation of (Quantitative) Structure-activity Relationships [(Q)SAR] Models
-
-
-
39
-
-
15244344542
-
Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man
-
DOI 10.1111/j.1742-7843.2005.pto960308.x
-
Parrott N,Jones H, Paquereau N, etal. Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmaco-kinetics to man. Basic Clin Pharmacol Toxicol 2005 Mar; 96 (3): 193-9. (Pubitemid 40387995)
-
(2005)
Basic and Clinical Pharmacology and Toxicology
, vol.96
, Issue.3
, pp. 193-199
-
-
Parrott, N.1
Jones, H.2
Paquereau, N.3
Lave, T.4
-
40
-
-
41949099850
-
Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: The first steps
-
Apr
-
Loizou G, Spendiff M, Barton HA, et al. Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps. Regul Toxicol Pharmacol 2008 Apr; 50 (3): 400-11.
-
(2008)
Regul Toxicol Pharmacol
, vol.50
, Issue.3
, pp. 400-411
-
-
Loizou, G.1
Spendiff, M.2
Barton, H.A.3
-
41
-
-
68249155031
-
Population-based mechanistic prediction of oral drug absorption
-
Jun
-
Jamei M, Turner D, Yang J, et al. Population-based mechanistic prediction of oral drug absorption. AAPS J 2009 Jun; 11 (2): 225-37.
-
(2009)
AAPS J
, vol.11
, Issue.2
, pp. 225-237
-
-
Jamei, M.1
Turner, D.2
Yang, J.3
-
42
-
-
38449107736
-
Characterizing uncertainty and variability in physiologically based pharmacokinetic models: State of the science and needs for research and implementation
-
DOI 10.1093/toxsci/kfm100
-
Barton HA, Chiu WA, Setzer W, et al. Characterizing uncertainty and vari- ability in physiologically-based pharmacokinetic (PBPK) models: state of the science and needs for research and implementation. Toxicol Sci 2007 Oct; 99 (2): 395-402. (Pubitemid 351753057)
-
(2007)
Toxicological Sciences
, vol.99
, Issue.2
, pp. 395-402
-
-
Barton, H.A.1
Chiu, W.A.2
Woodrow Setzer, R.3
Andersen, M.E.4
Bailer, A.J.5
Bois, F.Y.6
Dewoskin, R.S.7
Hays, S.8
Johanson, G.9
Jones, N.10
Loizou, G.11
Macphail, R.C.12
Portier, C.J.13
Spendiff, M.14
Tan, Y.-M.15
-
43
-
-
38649110420
-
Physiologically-based kinetic modelling (PBK modelling): Meeting the 3Rs agenda. The report and recommendations of ECVAM workshop 63
-
Bouvier d'Yvoire M, Prieto P, Blaauboer BJ, et al. Physiologically-based ki- netic modelling (PBK modelling): meeting the 3Rs agenda. The report and recommendationsofECVAM Workshop 63a. Altern Lab Anim 2007 Dec; 35 (6): 661-71. (Pubitemid 351169738)
-
(2007)
ATLA Alternatives to Laboratory Animals
, vol.35
, Issue.6
, pp. 661-671
-
-
Bouvier D'Yvoire, M.1
Prieto, P.2
Blaauboer, B.J.3
Bois, F.Y.4
Boobis, A.5
Brochot, C.6
Coecke, S.7
Freidig, A.8
Gundert-Remy, U.9
Hartung, T.10
Jacobs, M.N.11
Lave, T.12
Leahy, D.E.13
Lennernas, H.14
Loizou, G.D.15
Meek, B.16
Pease, C.17
Rowland, M.18
Spendiff, M.19
Yang, J.20
Zeilmaker, M.21
more..
-
44
-
-
52649130373
-
Whole body physiologically-based pharmacokinetic models: Their use in clinical drug development
-
Edginton AN, Theil FP, Schmitt W, et al. Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opin Drug Metab Toxicol 2008; 4 (9): 1143-52.
-
(2008)
Expert Opin Drug Metab Toxicol
, vol.4
, Issue.9
, pp. 1143-1152
-
-
Edginton, A.N.1
Theil, F.P.2
Schmitt, W.3
-
45
-
-
33947587274
-
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
-
DOI 10.1038/nrd2173, PII NRD2173
-
Rostami-Hodjegan A, Tucker GT. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat Rev Drug Discov 2007 Feb; 6 (2): 140-8. (Pubitemid 46745341)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.2
, pp. 140-148
-
-
Rostami-Hodjegan, A.1
Tucker, G.T.2
-
48
-
-
77953806651
-
Multiscale modeling in drug discovery and development: Future oppor- tunities and present challenges
-
Jul
-
Vicini P. Multiscale modeling in drug discovery and development: future oppor- tunities and present challenges. Clin Pharmacol Ther 2010 Jul; 88 (1): 126-9
-
(2010)
Clin Pharmacol Ther
, vol.88
, Issue.1
, pp. 126-129
-
-
Vicini, P.1
|